In today’s biopharma landscape, innovation alone isn’t enough. The road from breakthrough science to patient impact has never been more complex — with rising costs, shifting regulations, and a fiercely competitive market where winners and failures are increasingly defined early.
In this exclusive interview, Tom Murtagh, Joint Global Practice Lead, Strategy & Insight at Lumanity devles into the strategic “value inflection points” and how they can make or break a medicine’s commercial success. From breaking down silos between clinical, regulatory, and commercial teams, to harnessing AI and predictive analytics for faster market access, the conversation offers practical insights for leaders navigating this high-stakes environment.
Watch now to learn how harmonizing strategy, evidence generation, and stakeholder engagement can ensure new therapies reach the market with a clear, compelling value proposition — and deliver lasting impact for patients.
